好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2020 Annual Meeting | C133 - Neurologic Conditions in Transgender Patients

Tuesday 04/28/20
07:00 AM - 09:00 AM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Seminar
Riley Bove, MD, FAAN, Nicole Rosendale, MD
General Neurology
Upon completion of this course, participants will be able to define terminology and concepts related to gender identity and gender affirming care; describe the intersection between transgender identity and particular neurologic conditions, such as stroke and epilepsy; and explain, using a framework of neuroendocrine mechanisms, why transgender individuals using gender-affirming hormones may be at higher risk of particular neurologic conditions, such as cerebrovascular disease.
2.00 CME credits
Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Systems-based Practice
Introductory
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Case-based, Didactic, Audience Participation
Event Timeline
07:00 AM - 07:30 AM Speaker Introduction to Transgender Health
Nicole Rosendale, MD
07:30 AM - 08:00 AM Speaker Transgender Neuroepidemiology
Nicole Rosendale, MD
08:00 AM - 08:30 AM Speaker Neuroendocrine Mechanisms of Transgender Health
08:30 AM - 09:00 AM Discussion Case Review and Questions
Faculty Disclosures
Riley Bove, MD, FAAN Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for NeurologyLive. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Bove has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jansen. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cadenza. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Bove has received research support from Biogen. The institution of Dr. Bove has received research support from Roche Genentech. The institution of Dr. Bove has received research support from Novartis. The institution of Dr. Bove has received research support from Eli Lilly.
Nicole Rosendale, MD Dr. Rosendale has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum. The institution of Dr. Rosendale has received research support from 好色先生. The institution of Dr. Rosendale has received research support from NIH StrokeNet Fellowship. The institution of Dr. Rosendale has received research support from The Dana Foundation. The institution of Dr. Rosendale has received research support from UArizona-Banner All of Us Seed Grant. Dr. Rosendale has received publishing royalties from a publication relating to health care.
Starane A. Shepherd, MD Dr. Shepherd has nothing to disclose.